Russell Investments Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.8K | Sell |
2,558
-83
| -3% | -$1.16K | ﹤0.01% | 3060 |
|
2025
Q1 | $35.9K | Sell |
2,641
-19,475
| -88% | -$265K | ﹤0.01% | 2978 |
|
2024
Q4 | $451K | Buy |
22,116
+142
| +0.6% | +$2.89K | ﹤0.01% | 2302 |
|
2024
Q3 | $640K | Sell |
21,974
-940
| -4% | -$27.4K | ﹤0.01% | 2196 |
|
2024
Q2 | $532K | Sell |
22,914
-62,714
| -73% | -$1.46M | ﹤0.01% | 2175 |
|
2024
Q1 | $1.76M | Sell |
85,628
-25,845
| -23% | -$530K | ﹤0.01% | 1711 |
|
2023
Q4 | $2.39M | Sell |
111,473
-2,585
| -2% | -$55.5K | ﹤0.01% | 1517 |
|
2023
Q3 | $2.35M | Buy |
114,058
+7,244
| +7% | +$149K | ﹤0.01% | 1456 |
|
2023
Q2 | $3.15M | Buy |
106,814
+24,519
| +30% | +$724K | 0.01% | 1303 |
|
2023
Q1 | $1.9M | Sell |
82,295
-17,078
| -17% | -$393K | ﹤0.01% | 1618 |
|
2022
Q4 | $2.76M | Sell |
99,373
-7,488
| -7% | -$208K | 0.01% | 1389 |
|
2022
Q3 | $3.28M | Buy |
106,861
+18,631
| +21% | +$571K | 0.01% | 1290 |
|
2022
Q2 | $2.6M | Buy |
88,230
+36,710
| +71% | +$1.08M | 0.01% | 1447 |
|
2022
Q1 | $1.66M | Sell |
51,520
-14,601
| -22% | -$469K | ﹤0.01% | 1729 |
|
2021
Q4 | $2.95M | Buy |
66,121
+770
| +1% | +$34.4K | ﹤0.01% | 1586 |
|
2021
Q3 | $3.28M | Buy |
65,351
+1,594
| +3% | +$80.1K | 0.01% | 1506 |
|
2021
Q2 | $4.99M | Buy |
63,757
+15,791
| +33% | +$1.23M | 0.01% | 1354 |
|
2021
Q1 | $2.73M | Sell |
47,966
-32,129
| -40% | -$1.83M | ﹤0.01% | 1709 |
|
2020
Q4 | $6.71M | Buy |
80,095
+25,496
| +47% | +$2.14M | 0.01% | 1079 |
|
2020
Q3 | $1.96M | Hold |
54,599
| – | – | ﹤0.01% | 1703 |
|
2020
Q2 | $1.32M | Sell |
54,599
-17,130
| -24% | -$414K | ﹤0.01% | 1886 |
|
2020
Q1 | $1.26M | Sell |
71,729
-45,190
| -39% | -$791K | ﹤0.01% | 1732 |
|
2019
Q4 | $2.04M | Buy |
116,919
+47,796
| +69% | +$832K | ﹤0.01% | 1731 |
|
2019
Q3 | $1.06M | Buy |
69,123
+33,583
| +94% | +$515K | ﹤0.01% | 1980 |
|
2019
Q2 | $736K | Buy |
35,540
+9,650
| +37% | +$200K | ﹤0.01% | 2116 |
|
2019
Q1 | $601K | Buy |
25,890
+9,094
| +54% | +$211K | ﹤0.01% | 2282 |
|
2018
Q4 | $347K | Buy |
+16,796
| New | +$347K | ﹤0.01% | 2435 |
|